 | • レポートコード：MRC2012A1536 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ブランド薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。ブランド薬品の種類別市場規模（バイオ医薬品、化学薬品）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Gilead Sciences、Johnson & Johnson、Roche、AbbVie、Sanofi、Amgen、Novartis、Merck & Co. (MSD)、GlaxoSmithKline (GSK)、Bayer、Takeda、AstraZeneca、Takeda、Novo Nordisk、Teva、Bristol-Myers Squibb、Boehringer Ingelheim、Allergan、Eli Lilly、 ・地域別グローバル市場分析 2015年-2020年 ・ブランド薬品の北米市場（アメリカ、カナダ、メキシコ） ・ブランド薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ブランド薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ブランド薬品の南米市場（ブラジル、アルゼンチン） ・ブランド薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：バイオ医薬品、化学薬品 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Brand Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Brand Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Brand Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Brand Drugs market has been segmented into
Biopharmaceutical
Chemistry Medicine
By Application, Brand Drugs has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Brand Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Brand Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Brand Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Brand Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Brand Drugs Market Share Analysis
Brand Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Brand Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Brand Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Brand Drugs are:
Pfizer
Gilead Sciences
Johnson & Johnson
Roche
AbbVie
Sanofi
Amgen
Novartis
Merck & Co. (MSD)
GlaxoSmithKline (GSK)
Bayer
Takeda
AstraZeneca
Takeda
Novo Nordisk
Teva
Bristol-Myers Squibb
Boehringer Ingelheim
Allergan
Eli Lilly
Among other players domestic and global, Brand Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Brand Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Brand Drugs, with price, sales, revenue and global market share of Brand Drugs in 2018 and 2019.
Chapter 3, the Brand Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Brand Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Brand Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Brand Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Brand Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Brand Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Biopharmaceutical
1.2.3 Chemistry Medicine
1.3 Market Analysis by Application
1.3.1 Overview: Global Brand Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global Brand Drugs Market
1.4.1 Global Brand Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck & Co. (MSD)
2.9.1 Merck & Co. (MSD) Details
2.9.2 Merck & Co. (MSD) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck & Co. (MSD) SWOT Analysis
2.9.4 Merck & Co. (MSD) Product and Services
2.9.5 Merck & Co. (MSD) Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline (GSK)
2.10.1 GlaxoSmithKline (GSK) Details
2.10.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline (GSK) SWOT Analysis
2.10.4 GlaxoSmithKline (GSK) Product and Services
2.10.5 GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AstraZeneca SWOT Analysis
2.13.4 AstraZeneca Product and Services
2.13.5 AstraZeneca Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda
2.14.1 Takeda Details
2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda SWOT Analysis
2.14.4 Takeda Product and Services
2.14.5 Takeda Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novo Nordisk SWOT Analysis
2.15.4 Novo Nordisk Product and Services
2.15.5 Novo Nordisk Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Teva SWOT Analysis
2.16.4 Teva Product and Services
2.16.5 Teva Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bristol-Myers Squibb
2.17.1 Bristol-Myers Squibb Details
2.17.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bristol-Myers Squibb SWOT Analysis
2.17.4 Bristol-Myers Squibb Product and Services
2.17.5 Bristol-Myers Squibb Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Boehringer Ingelheim SWOT Analysis
2.18.4 Boehringer Ingelheim Product and Services
2.18.5 Boehringer Ingelheim Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Allergan
2.19.1 Allergan Details
2.19.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Allergan SWOT Analysis
2.19.4 Allergan Product and Services
2.19.5 Allergan Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Eli Lilly
2.20.1 Eli Lilly Details
2.20.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Eli Lilly SWOT Analysis
2.20.4 Eli Lilly Product and Services
2.20.5 Eli Lilly Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Brand Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Brand Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Brand Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Brand Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Brand Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Brand Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Brand Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Brand Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Brand Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Brand Drugs Sales and Growth Rate (2015-2020)
4.5 South America Brand Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Brand Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Brand Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Brand Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Brand Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Brand Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Brand Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Brand Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Brand Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Brand Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Brand Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Brand Drugs Sales and Growth Rate (2015-2020)
6.3 UK Brand Drugs Sales and Growth Rate (2015-2020)
6.4 France Brand Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Brand Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Brand Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Brand Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Brand Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Brand Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Brand Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Brand Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Brand Drugs Sales and Growth Rate (2015-2020)
7.5 India Brand Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Brand Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Brand Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Brand Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Brand Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Brand Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Brand Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Brand Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Brand Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Brand Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Brand Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Brand Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Brand Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Brand Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Brand Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Brand Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Brand Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Brand Drugs Price by Type (2015-2020)
11 Global Brand Drugs Market Segment by Application
11.1 Global Brand Drugs Sales Market Share by Application (2015-2020)
11.2 Global Brand Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Brand Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Brand Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Brand Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Brand Drugs Market Forecast (2021-2025)
12.2.2 Europe Brand Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Brand Drugs Market Forecast (2021-2025)
12.2.4 South America Brand Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Brand Drugs Market Forecast (2021-2025)
12.3 Brand Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Brand Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Brand Drugs Market Share Forecast by Type (2021-2025)
12.4 Brand Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Brand Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Brand Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Brand Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Brand Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Brand Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Brand Drugs Major Business
Table 9. Pfizer Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Brand Drugs Product and Services
Table 12. Pfizer Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 14. Gilead Sciences Brand Drugs Major Business
Table 15. Gilead Sciences Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Gilead Sciences SWOT Analysis
Table 17. Gilead Sciences Brand Drugs Product and Services
Table 18. Gilead Sciences Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Brand Drugs Major Business
Table 21. Johnson & Johnson Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Brand Drugs Product and Services
Table 24. Johnson & Johnson Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Roche Basic Information, Manufacturing Base and Competitors
Table 26. Roche Brand Drugs Major Business
Table 27. Roche Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Roche SWOT Analysis
Table 29. Roche Brand Drugs Product and Services
Table 30. Roche Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Brand Drugs Major Business
Table 33. AbbVie Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 34. AbbVie SWOT Analysis
Table 35. AbbVie Brand Drugs Product and Services
Table 36. AbbVie Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Brand Drugs Major Business
Table 39. Sanofi Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Brand Drugs Product and Services
Table 42. Sanofi Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Amgen Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Brand Drugs Major Business
Table 45. Amgen Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Amgen SWOT Analysis
Table 47. Amgen Brand Drugs Product and Services
Table 48. Amgen Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Brand Drugs Major Business
Table 51. Novartis Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Brand Drugs Product and Services
Table 54. Novartis Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Merck & Co. (MSD) Basic Information, Manufacturing Base and Competitors
Table 56. Merck & Co. (MSD) Brand Drugs Major Business
Table 57. Merck & Co. (MSD) Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Merck & Co. (MSD) SWOT Analysis
Table 59. Merck & Co. (MSD) Brand Drugs Product and Services
Table 60. Merck & Co. (MSD) Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline (GSK) Brand Drugs Major Business
Table 63. GlaxoSmithKline (GSK) Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 64. GlaxoSmithKline (GSK) SWOT Analysis
Table 65. GlaxoSmithKline (GSK) Brand Drugs Product and Services
Table 66. GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Brand Drugs Major Business
Table 69. Bayer Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Bayer SWOT Analysis
Table 71. Bayer Brand Drugs Product and Services
Table 72. Bayer Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Takeda Basic Information, Manufacturing Base and Competitors
Table 74. Takeda Brand Drugs Major Business
Table 75. Takeda Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Takeda SWOT Analysis
Table 77. Takeda Brand Drugs Product and Services
Table 78. Takeda Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Brand Drugs Major Business
Table 81. AstraZeneca Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 82. AstraZeneca SWOT Analysis
Table 83. AstraZeneca Brand Drugs Product and Services
Table 84. AstraZeneca Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Brand Drugs Major Business
Table 87. Takeda Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Takeda SWOT Analysis
Table 89. Takeda Brand Drugs Product and Services
Table 90. Takeda Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 92. Novo Nordisk Brand Drugs Major Business
Table 93. Novo Nordisk Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Novo Nordisk SWOT Analysis
Table 95. Novo Nordisk Brand Drugs Product and Services
Table 96. Novo Nordisk Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Teva Basic Information, Manufacturing Base and Competitors
Table 98. Teva Brand Drugs Major Business
Table 99. Teva Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Teva SWOT Analysis
Table 101. Teva Brand Drugs Product and Services
Table 102. Teva Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb Brand Drugs Major Business
Table 105. Bristol-Myers Squibb Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Bristol-Myers Squibb SWOT Analysis
Table 107. Bristol-Myers Squibb Brand Drugs Product and Services
Table 108. Bristol-Myers Squibb Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Boehringer Ingelheim Brand Drugs Type and Application
Table 110. Boehringer Ingelheim Brand Drugs Major Business
Table 111. Boehringer Ingelheim Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Boehringer Ingelheim SWOT Analysis
Table 113. Boehringer Ingelheim Brand Drugs Product and Services
Table 114. Boehringer Ingelheim Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Allergan Basic Information, Manufacturing Base and Competitors
Table 116. Allergan Brand Drugs Major Business
Table 117. Allergan Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 118. Allergan SWOT Analysis
Table 119. Allergan Brand Drugs Product and Services
Table 120. Allergan Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 122. Eli Lilly Brand Drugs Major Business
Table 123. Eli Lilly Brand Drugs Total Revenue (USD Million) (2017-2018)
Table 124. Eli Lilly SWOT Analysis
Table 125. Eli Lilly Brand Drugs Product and Services
Table 126. Eli Lilly Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Brand Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 128. Global Brand Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Brand Drugs Sales by Regions (2015-2020) (K Units)
Table 130. Global Brand Drugs Sales Market Share by Regions (2015-2020)
Table 131. Global Brand Drugs Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Brand Drugs Sales by Countries (2015-2020) (K Units)
Table 133. North America Brand Drugs Sales Market Share by Countries (2015-2020)
Table 134. North America Brand Drugs Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Brand Drugs Revenue Market Share by Countries (2015-2020)
Table 136. Europe Brand Drugs Sales by Countries (2015-2020) (K Units)
Table 137. Europe Brand Drugs Sales Market Share by Countries (2015-2020)
Table 138. Europe Brand Drugs Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Brand Drugs Sales by Regions (2015-2020) (K Units)
Table 140. Asia-Pacific Brand Drugs Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Brand Drugs Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Brand Drugs Sales by Countries (2015-2020) (K Units)
Table 143. South America Brand Drugs Sales Market Share by Countries (2015-2020)
Table 144. South America Brand Drugs Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Brand Drugs Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Brand Drugs Sales by Countries (2015-2020) (K Units)
Table 147. Middle East & Africa Brand Drugs Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Brand Drugs Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Brand Drugs Revenue Market Share by Countries (2015-2020)
Table 150. Global Brand Drugs Sales by Type (2015-2020) (K Units)
Table 151. Global Brand Drugs Sales Share by Type (2015-2020)
Table 152. Global Brand Drugs Revenue by Type (2015-2020) (USD Million)
Table 153. Global Brand Drugs Revenue Share by Type (2015-2020)
Table 154. Global Brand Drugs Sales by Application (2015-2020) (K Units)
Table 155. Global Brand Drugs Sales Share by Application (2015-2020)
Table 156. Global Brand Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 157. Global Brand Drugs Market Share Forecast by Regions (2021-2025)
Table 158. Global Brand Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 159. Global Brand Drugs Market Share Forecast by Type (2021-2025)
Table 160. Global Brand Drugs Sales Forecast by Application (2021-2025)
Table 161. Global Brand Drugs Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Brand Drugs Picture
Figure 2. Global Sales Market Share of Brand Drugs by Type in 2019
Figure 3. Biopharmaceutical Picture
Figure 4. Chemistry Medicine Picture
Figure 5. Brand Drugs Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Brand Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Brand Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Brand Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Brand Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Brand Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Brand Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Brand Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Brand Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Brand Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Brand Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Brand Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Brand Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Brand Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Brand Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Brand Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Brand Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Brand Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Brand Drugs Sales Market Share by Countries in 2018
Figure 46. North America Brand Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Brand Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Brand Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Brand Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Brand Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Brand Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Brand Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Brand Drugs Revenue Market Share by Regions 2019
Figure 62. China Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Brand Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Brand Drugs Sales Market Share by Countries in 2019
Figure 69. South America Brand Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Brand Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Brand Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Brand Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Brand Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Brand Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Brand Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Brand Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Brand Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Brand Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Brand Drugs Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Brand Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Brand Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
MICE・商標活性化の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The MICE and Brand Activation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 鉄剤の世界市場（～2026年） Iron is required to transport oxygen through haemoglobin in red blood cells (RBCs) and oxidize cells through cytochrome. Iron deficiency is a common cause of anaemia. Iron drugs are used to treat people with iron deficiency. In terms of geographic regions, the North Americas accounted for the major …
- イロプロスト治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Iloprost Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…